Evaluate the Auxiliary Diagnostic Value of Circulating Tumor Cells in Benign and Malignant Lung Nodules

NCT ID: NCT02653859

Last Updated: 2016-01-12

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 50 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2016-01-31

Brief Summary

By testing the CTC number of new solitary pulmonary nodule patient, evaluating the correlation of CTC number and benign and malignant lung nodules auxiliary diagnosis, the correlation of CTC number and the size of lung nodules of the malignant patients, the correlation between the CTC number and subtypes of malignant lung nodules patients.The CTC and tumor markers will be detected before the patient received treatment. Tumor markers include Pro-GRP, NSE, CEA, CYFRA211, SCC.

Conditions

Solitary Pulmonary Nodule

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Eligibility Criteria

Inclusion Criteria

• New Solitary Pulmonary Nodule patients
• first visit patient
• Heart, liver and kidney function is normal.
• 18-80 years old.
• Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria

• Blood collection time is not in the scheduled time.
• The plasma sample hemolysis or condensation.
• Whole blood samples less than 3 ml.
• poor compliance

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

Sponsor Role: collaborator

GenoSaber

INDUSTRY

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Other Identifiers

CTC2015-02

Identifier Type: -

Identifier Source: org_study_id